ArticleAnalytical and bioanalytical chemistry2026
A label-free and highly sensitive fluorescence aptasensor for enrofloxacin detection based on G-triplex-mediated signal amplification.
Article in Analytical and bioanalytical chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Enrofloxacin (ENR), a third-generation fluoroquinolone veterinary antibiotic, is widely used in aquaculture and animal husbandry for bacterial infection control due to its broad-spectrum antimicrobial activity, potent bactericidal efficacy, and cost-effectiveness. However, its excessive and non-standard use has caused widespread residues in animal-derived foods, which pose severe risks to human gastrointestinal, nervous and hepatorenal systems, induce bacterial resistance, and threaten global food safety and ecological sustainability. Herein, we developed a label-free, rapid, and highly sensitive fluorescence aptasensor for ENR detection based on G-triplex signal amplification. The ENR-specific aptamer was pre-hybridized with a guanine-rich sequence to suppress G-triplex formation and maintain a low thioflavin T (ThT) background. Upon ENR addition, target binding releases the guanine-rich strand, which folds into a stable G-triplex and strongly enhances ThT fluorescence for quantitative detection. Under optimal conditions, this aptasensor showed a linear range of 1.0 nM to 1.0 μM (R
Indexed as
Identifiers
42604867What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.